# Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Sickle Cell Disease

> clinical trial · VERIFIED · 2026-07-16

Status: NOT_YET_RECRUITING · Sponsor: Daniel Bauer · Condition: Sickle Cell Disease

- Company: Daniel Bauer
- Sector: genomics
- Primary source: https://clinicaltrials.gov/study/NCT07708350

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.